InChI=1S/C45H66O16/c1- 9- 10- 11- 12- 13- 14- 37(49) 59- 41- 29(21- 39(51) 56- 8) 20- 32- 24- 35(27(2) 46) 58- 40(52) 23- 30(47) 22- 33- 25- 36(48) 43(5,6) 44(53,60- 33) 26- 34- 18- 28(19- 38(50) 55- 7) 17- 31(57- 34) 15- 16- 42(3,4) 45(41,54) 61- 32/h11- 16,19,21,27,30- 36,41,46- 48,53- 54H,9- 10,17- 18,20,22- 26H2,1- 8H3/b12- 11+,14- 13+,16- 15+,28- 19+,29- 21+/t27- ,30- ,31+,32+,33- ,34+,35- ,36+,41+,44+,45- /m1/s1 |
LIPGUSBNMQRYNL-IZBIBDMISA-N |
C/1(\C[C@H] 2O[C@@H] (C1) C[C@] 3(C([C@H] (C[C@@H] (C[C@H] (CC(O[C@@H] ([C@@H] (C) O) C[C@@] 4(C\C(\[C@@H] ([C@] (C(C=C2) (C) C) (O4) O) OC(/C=C/C=C/CCC) =O) =C/C(OC) =O) [H] ) =O) O) O3) O) (C) C) O) =C\C(OC) =O |
|
Bugula neritina
(NCBI:txid10212)
|
See:
J. Nat. Prod., 1983, v46, 528-531
|
protein kinase C agonist
An agonist that selectively binds to and activates a protein kinase C receptor
marine metabolite
Any metabolite produced during a metabolic reaction in marine macro- and microorganisms.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)- 1,11,21,25- tetrahydroxy- 17- [(1R)- 1- hydroxyethyl]- 5,13- bis(2- methoxy- 2- oxoethylidene)- 10,10,26,26- tetramethyl- 19- oxo- 18,27,28,29- tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos- 8- en- 12- yl (2E,4E)- octa- 2,4- dienoate
|
(+)-bryostatin 2
|
ChEBI
|
7-O-deacetylbryostatin 1
|
ChemIDplus
|
8306043
|
Reaxys Registry Number
|
Reaxys
|
87745-28-6
|
CAS Registry Number
|
ChemIDplus
|
1904062
|
PubMed citation
|
Europe PMC
|
2334938
|
PubMed citation
|
Europe PMC
|
2720677
|
PubMed citation
|
Europe PMC
|
2910827
|
PubMed citation
|
Europe PMC
|
|